IL23R and rheumatoid arthritis: There is evidence to suggest that mutations in the interleukin-23 receptor (IL23R) gene could confer increased susceptibility to AI conditions, such as RA, psoriasis and TED (21–23), which may explain the association of RA and psoriasis in our cohort.